Technologically Advanced Wound Care Management Products to Favor Diabetic Foot Ulcer Market Growth During 2021–2028
According to our new research study on “Diabetic Foot Ulcer Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type, Ulcer Type, and End User,” the market is expected to reach US$ 7,793.83 million by 2028 from US$ 4,279.65 million in 2020; it is estimated to grow at a CAGR of 7.9% from 2021 to 2028. The report highlights major market drivers and prominent companies along with their key developments in the market.
Skin tissue damage caused by various indications due to diabetes, and vascular diseases poses a significant burden on healthcare systems of different countries. 3D bioprinting is an approach based on layer-based synthesis, wherein the newly generated cells and cell-based materials can be dispensed to mimic native tissues. Though the technology is still in its early phase, 3D printing has a potential to revolutionize the wound care industry. Many companies are involved in developing new products involving ion-release biomaterials that will promote angiogenesis for dermal regeneration. In addition, 3D bioprinting is helping in patching large wounds that are hard to heal with standard techniques. In February 2019, researchers at Wake Forest Institute for Regenerative Medicine (WFIRM) developed a new bioprinter that can print dual layers of skin directly into a patient’s wound. For instance, in September 2019, AngioDerm, a project focused on regenerative medicine, received a European grant of US$ 822,000 to provide a solution for dermal regeneration for helping patients with ulcers or major burns that fail to heal. The funding was announced for five European institutions and companies working in collaboration on the project. Thus, the use of 3D bioprinting technologies in ulcer or wound treatments is likely to emerge as a prominent trend in the diabetic foot ulcer treatment market in the coming years.
Geographically, the diabetic foot ulcer market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). North America held the largest market share in 2020. In 2020, the US held the largest share of the market in North America. The market growth in North America is attributed to the key driving factors such as the rising prevalence of diabetic foot ulcers, surging incidence of diabetes, and availability of advanced treatment for diabetic foot ulcer.
ConvaTec Inc; 3M Company (Acelity L.P. Inc.); Coloplast A/S; Smith & Nephew plc; B. Braun Melsungen AG; Medline Industries, Inc; Cardinal Health Inc; Organogenesis Holdings Inc; Mölnlycke Health Care; MiMedx Group, Inc; Kerecis hf; and URGO are among the leading companies operating in the diabetic foot ulcer market.
The report analyzes diabetic foot ulcer market on the basis of following segments:
- Advanced Wound Care Dressings
- Therapy Device
- By Ulcer Type
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
By End User
- Ambulatory Surgery Centers
- Home Care
Diabetic Foot Ulcer Market, by Geography
Contact UsContact Person: Sameer JoshiPhone: +1-646-491-9876Email Id: email@example.com
- North America
- Rest of Europe
- Asia Pacific (APAC)
- South Korea
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Rest of South and Central America